Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ID › Idaho Falls › NPI 1790052603
Physician

Premier Eye Care of Eastern Idaho

Premier Eye Care of Eastern Idaho was paid $1.44M by Medicaid between Jan 2018 and Dec 2024, across 16 billing codes. Its largest line is J2778, Injection, ranibizumab, 0.1 mg — 70% of everything it billed.

33Billing provider infoPREMIER EYE CARE OF EASTERN IDAHO
IDAHO FALLS, ID 83404
33aNPI1790052603assigned 11/20/2011
33bProvider typeOphthalmology Physician
28Total paid$1.44M
24GClaims10,862
24DCodes billed16
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ophthalmology Physician providers in Idaho

Rank by total paid#2 of 22
Median peer was paid$43K
This provider vs. median34×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018729$18K
2019811$24K
20201,015$49K
20211,577$90K
20222,153$397K
20232,403$519K
2024incomplete2,174$338K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J2778 Injection, ranibizumab, 0.1 mg 70% 1,245 1,152 $1.00M
67028 Intravitreal injection of a pharmacologic agent 13% 3,212 2,878 $180K
92134 4.9% 3,087 2,681 $70K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 3.9% 1,076 1,013 $56K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.8% 683 635 $40K
J9035 Injection, bevacizumab, 10 mg 1.4% 291 279 $20K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.2% 243 241 $17K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 247 231 $14K
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg <1% 14 14 $12K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 102 101 $11K
92250 <1% 278 263 $7K
J7999 Compounded drug, not otherwise classified <1% 246 216 $4K
4 more codes
99203 Doctor's office visit, new patient (routine) <1% 28 $3K
92133 <1% 54 $694.23
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 17 $563.55
92015 Determination of refractive state <1% 39 $180.09

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTRAYNOR, MATTHEW (OWNER)